GlassScriptPhysician profile
Cristina E Farrell
NPI 1134385842
$654.42
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Developmental - Behavioral Pediatrics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $48.07 · 2021: $101 · 2022: $99.73 · 2023: $118 · 2024: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $189.62 | 2021-2024 | Qelbree, Qelbree |
| Neos Therapeutics, LP | $154.95 | 2019-2023 | Cotempla Xr-Odt |
| Tris Pharma INC | $111.19 | 2019-2024 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $60.62 | 2019-2023 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $29.14 | 2019-2020 | |
| Corium, LLC | $28.14 | 2023-2024 | Azstarys, Azstarys |
| Adlon Therapeutics L.P. | $25.05 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $16.27 | 2023 | Daybue |
| Shire North American Group INC | $13.84 | 2019 | |
| Vertical Pharmaceuticals, LLC | $13.13 | 2019 | |
| Rhodes Pharmaceuticals L.P. | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cristina Farrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.